Doksorubicyna - nowe oblicze starego leku
Natalia Lipińska(Poznan University of Medical Sciences), Błażej Rubiś(Poznan University of Medical Sciences), Hanna Hołysz(Poznan University of Medical Sciences), Przemysław Kopczyński(Poznan University of Medical Sciences)
Postepy Biologii Komorki
January 1, 2013
Cited by 0
Related Papers
Vitamin C as a Modulator of the Response to Cancer Therapy
|Molecules|2019|104
Telomerase and drug resistance in cancer
|Cellular and Molecular Life Sciences|2017|102
The non-canonical functions of telomerase: to turn off or not to turn off
|Molecular Biology Reports|2018|61
Telomerase Inhibitor TMPyP4 Alters Adhesion and Migration of Breast-Cancer Cells MCF7 and MDA-MB-231
|International Journal of Molecular Sciences|2019|42
The Role of Telomerase in Breast Cancer’s Response to Therapy
|International Journal of Molecular Sciences|2022|39